Better drugs faster.

One Platform

Accelerates Drug Discovery

Celeris One™

Celeris One™

Target Discovery

Automated phenotypic screening and sequencing to identify and validate pathogenic proteins. We are using active learning and data augmentation with in silico computations and in vitro experiments for rapid target discovery.

From Disease to Target

Drug Discovery

We screen targets within the human proteome for potential off- and anti-targets, thus identifying adversarial effects. Once these hidden relationships are identified, existing databases with millions of small molecules are exploited to find the most specific ligands to targets. By deeply understanding the chemical space we exploit, we generate novel ligands based on predicted molecular properties.

From Target to Hit to Lead

Automated Lab Validation

Deep learning aided synthesis planning allows generating the leads to automatically validate them in an automated lab. By iterating the validation results with the previous module, we generate more leads tailored to desired properties.

From Lead to Validation

Better drugs faster.

We are CelerisTx

We are an international team of highly skilled experts from disciplines as computational chemistry, medicinal chemistry, biology and machine learning.

Our team is complemented by highly esteemed advisors and investors at the intersection of artificial intelligence and life sciences.

One Team. One Vision.


DI Christopher Trummer, MSc.


Jakob Hohenberger


Noah Weber, MSc


Hosein Fooladi, MSc



DI Christopher Trummer, MSc.


Jakob Hohenberger


Petr Šrámek, MBA


Dr. Ronjon Nag

Board Member

Dr. Siham Ceballos

Board Member

Scientific Advisors

Prof. Dr. Jean-Louis Reymond

Former Dir. of Chemistry and Biochemistry at the University of Bern.

Assoc.-Prof. Dr. Johannes Kirchmair

Head of Comp. Drug Discovery and Design at the University of Vienna.

Assist.-Prof. Dr. Günter Klambauer

Ass. Professor at the Johannes Kepler University Linz for AI.

Prof. Dr. Ola Spjuth

Professor at the University of Uppsala.

Open positions

Go to Careers to view the open positions.

Our Investors

Our Supporters


Stay tuned

Join our newsletter to receive the latest news.

Thanks for your subscription!